Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission v1

View through CrossRef
Background: Proteinuria is a powerful prognostic factor for end-stage renal disease in IgA nephropathy (IgAN) patients. However, it is not known whether proteinuria exacerbations are related to seasonal changes. Methods: We retrospectively enrolled consecutive patients diagnosed with IgAN by kidney biopsy at our hospital between 2002 and 2014. Proteinuria remission was defined as urinary protein <0.3 g/gCr in two consecutive outpatient urinalyses and exacerbation as urinary protein 竕・0.75 g/gCr. Four seasons were defined: spring (March- May), summer (June- August), autumn (September- November), and winter (December- February). We performed a multivariate analysis to identify factors associated with the second remission following a proteinuria exacerbation. Results: We analyzed 116 patients. Proteinuria remission and exacerbation occurred in 89, and 50 patients, respectively. The incidence of proteinuria exacerbation was significantly higher in autumn and winter than in spring and summer (p=0.040). The cumulative second remission rate was significantly higher in patients with autumn and winter proteinuria exacerbation than in patients with spring and summer exacerbations (p=0.010). In multivariate analyses, exacerbation onset in autumn and winter (HR, 3.36; 95% CI, 1.36- 8.34) and intensive therapy (HR, 2.68; 95% CI, 1.24- 5.80) were significantly associated with a second proteinuria remission. Conclusion: In IgAN patients in proteinuria remission, proteinuria exacerbation frequently occurred in autumn and winter. Exacerbations occurring in autumn and winter tended to remit early.
ZappyLab, Inc.
Title: Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission v1
Description:
Background: Proteinuria is a powerful prognostic factor for end-stage renal disease in IgA nephropathy (IgAN) patients.
However, it is not known whether proteinuria exacerbations are related to seasonal changes.
Methods: We retrospectively enrolled consecutive patients diagnosed with IgAN by kidney biopsy at our hospital between 2002 and 2014.
Proteinuria remission was defined as urinary protein <0.
3 g/gCr in two consecutive outpatient urinalyses and exacerbation as urinary protein 竕・0.
75 g/gCr.
Four seasons were defined: spring (March- May), summer (June- August), autumn (September- November), and winter (December- February).
We performed a multivariate analysis to identify factors associated with the second remission following a proteinuria exacerbation.
Results: We analyzed 116 patients.
Proteinuria remission and exacerbation occurred in 89, and 50 patients, respectively.
The incidence of proteinuria exacerbation was significantly higher in autumn and winter than in spring and summer (p=0.
040).
The cumulative second remission rate was significantly higher in patients with autumn and winter proteinuria exacerbation than in patients with spring and summer exacerbations (p=0.
010).
In multivariate analyses, exacerbation onset in autumn and winter (HR, 3.
36; 95% CI, 1.
36- 8.
34) and intensive therapy (HR, 2.
68; 95% CI, 1.
24- 5.
80) were significantly associated with a second proteinuria remission.
Conclusion: In IgAN patients in proteinuria remission, proteinuria exacerbation frequently occurred in autumn and winter.
Exacerbations occurring in autumn and winter tended to remit early.

Related Results

Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Abstract Chemical and functional properties of IgA binding factor(s) (IgA-BF) from both murine Con A-activated spleen cells and Fc gamma R+, Fc alpha R+ T hybridoma ...
Etiology of IgA nephropathy syndrome
Etiology of IgA nephropathy syndrome
Since Berger's original paper on mesangial IgA‐IgG deposition with hematuria, there have been a number of clinical and pathological studies regarding IgA immune complexes, the mech...
An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti‐IgA) and IgA deficiency
An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti‐IgA) and IgA deficiency
BACKGROUND: Immunoglobulin A antibodies (anti‐IgA) are rare but can cause transfusion‐associated anaphylaxis. The detection of anti‐IgA has traditionally been performed using a lab...
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age
ABSTRACTObjectives:The aim was to investigate age‐dependent serum levels and occurrence of elevated celiac disease (CD)–related antibodies in young children, to define the optimal ...
Effects of serial plasmapheresis on serum IgA levels in IgA‐deficient blood donors with IgA‐suppressor T cells
Effects of serial plasmapheresis on serum IgA levels in IgA‐deficient blood donors with IgA‐suppressor T cells
Seventeen IgA‐deficient blood donors, without antibodies to IgA, underwent plasmapheresis four to eight consecutive times at intervals of 8 weeks or less to provide fresh‐frozen pl...

Back to Top